"Factors" present in C F saliva had no detectable effect on salivary amylase activity under reaction conditions optimized for both competitive and noncompetitive inhibition. Tris [tris-(hydroxymethyl)aminomethanel inhibited amylase activity with a Ki = 59 f 10 mM, but C F "factors" had no detectable effect on either substrate or Tris binding to a-amylase. a-Amylase concentration and protein content of C F saliva had bimodal distributions. Thirty-six percent of the C F patients were found to be amylase hypersecretors, with amylase concentration 3 or more S D above the N mean. Amylase hypersecretion was marginally correlated with both genetic factors (with parent values, P = 0.075) and clinical status (with Shwachman scores, P = 0.068). All the hypersecretors were in the 14-24 year age group. Amylase concentration for this age was significantly higher in C F samples (mean f SD), 82 + 37 starch units/ml ( n = 12), than in N samples, 33 f 17 starch units/ml ( n = 13), a s measured by the Student t-test ( P < 0.001). Salivary protein content of 14-to 24-year-old C F males was elevated compared to all other groups 11.57 + 0.76 ( n = 5) vs. 0.63 2 0.47 ( n = 20); Student t-test, P < 0.0051. Mean specific activity of male saliva dropped sharply as age increased from 10-15 years, from over 200 to less than 75 starch units/mg protein. Mean normal female specific activity values were essentially constant 197 f 50 ( n = 18) starch units/mg protein1 from 5-30 years of age. C F male specific activity values decreased similarly to the N male values from preadolescence to adolescence, but the mean C F female values peaked later, at 17 years, with a maximum of 171 f 58 ( n = 4). This is significantly higher than all the other groups in the 16-to 20-year age range: 63 + 30 ( n = 9). P < 0.005. These data emphasize the need for ageand sex-matched controls in all studies of salivary composition.
Summary
exocrine secretions have also been found to have altered electrolyte a-Amylase activity and protein concentration of cystic fibrosis (CF), obligate heterozygote (H), and normal (N) saliva have been evaluated with respect to genotype, age, sex and clinical status.
"Factors" present in C F saliva had no detectable effect on salivary amylase activity under reaction conditions optimized for both competitive and noncompetitive inhibition. Tris [tris-(hydroxymethyl)aminomethanel inhibited amylase activity with a Ki = 59 f 10 mM, but C F "factors" had no detectable effect on either substrate or Tris binding to a-amylase. a-Amylase concentration and protein content of C F saliva had bimodal distributions. Thirty-six percent of the C F patients were found to be amylase hypersecretors, with amylase concentration 3 or more S D above the N mean. Amylase hypersecretion was marginally correlated with both genetic factors (with parent values, P = 0.075) and clinical status (with Shwachman scores, P = 0.068). All the hypersecretors were in the 14-24 year age group. Amylase concentration for this age was significantly higher in C F samples (mean f SD), 82 + 37 starch units/ml ( n = 12), than in N samples, 33 f 17 starch units/ml ( n = 13), a s measured by the Student t-test ( P < 0.001). Salivary protein content of 14-to 24-year-old C F males was elevated compared to all other groups 11.57 + 0.76 ( n = 5) vs. 0.63 2 0.47 ( n = 20); Student t-test, P < 0.0051. Mean specific activity of male saliva dropped sharply as age increased from 10-15 years, from over 200 to less than 75 starch units/mg protein. Mean normal female specific activity values were essentially constant 197 f 50 ( n = 18) starch units/mg protein1 from 5-30 years of age. C F male specific activity values decreased similarly to the N male values from preadolescence to adolescence, but the mean C F female values peaked later, at 17 years, with a maximum of 171 f 58 ( n = 4). This is significantly higher than all the other groups in the 16-to 20-year age range: 63 + 30 ( n = 9). P < 0.005. These data emphasize the need for ageand sex-matched controls in all studies of salivary composition. and protein content (31) . a-Amylase (14-a-D-glucan ~~l u c a n ohydrolase, E C 3.2.1.1) has been reported to be elevated in C F saliva (2, 18) . Whether the elevated a-amylase in C F is a reflection of a general increase in secretory protein concentration or a more specific manifestation of C F remains to be determined.
Ciliary dyskinesia factor(s) (CDF) have been found in the serum. saliva, and urine of C F homozygotes and heterozygotes. These C F body fluids interfere with the normal beat of various ciliated preparations (9, 19, 28) . The salivary C D F appears to be associated with a-amylase (1, 8, 9, 11). a-Amylase purified from C F but not N saliva possesses C D F activity on oyster gills (I. 21).
C D F and a-amylase activities coprecipitate from saliva (8. 11). The two activities can be separated by extended dialysis (I I). The small molecular weight salivary C D F fraction is capable of inhibiting mammalian debranching enzyme (1 1, 32).
Because of the close association of C D F and a-amylase in C F saliva, it was of interest to determine whether the presence of C D F could be detected in whole saliva by its effect on a-amylase activity. If C D F were found to affect a-amylase, this effect could be used to quantitate its concentration in whole saliva. The C D F effect on debranching enzyme indicates that the factor is capable of inhibiting carbohydrase activity (1 1). The standard saccharogenic assay for a-amylase is not affected by CDF in the saliva sample (1 1). A new assay for a-amylase has been developed which should be optimal for detecting C D F if this factor acts as a competitive or noncompetitive inhibitor of a-amylase (12) . This assay has been used to determine the effect of C D F on salivary a-amylase activity. In conjunction with this study, the saccharogenic a-amylase activity and the protein concentration of CF, H, and N saliva samples have also been determined, and analyzed as a function of genotype, age, sex, and clinical status of the saliva donor. The results presented here indicate that the magnitude of the differences between C F and N salivary a-amylase and protein are a function of age and sex.
Speculation
MATERIALS AND METHODS We were unable to detect any effect of a salivary C F factor on the enzymatic activity of a-amylase. Hypersecretion of salivary C F Saliva samples were donated by patientstreated at the Cystic a-amylasc was observed in %% of C F patients. This may reflect ~i b r o s i s Center, University of California at LOS Angeles (UCLA) alterations in secretory function basic to CF, or be secondary to School of Medicine-Obligate heterozygote (H) saliva samples the disease process and result from decreased secretion from the were obtained from Parents of C F patients. Normal (N) saliva mucous salivary glands or deterioration of pancreatic function.
Samples were obtained from donors with no family history of CF. The Human Subject Protection Committee at UCLA has approved the protocol and the Informed Consent Form used for Cystic fibrosis (CF) is one of the most common lethal genetic saliva collection. diseases of man. The basic defect is not yet known. It is characa-Amylase starch activity was determined at 30' in 50 mM terized by aberrant exocrine gland activity, progressive pulmonary maleate buffer, pH 6.5, using a modification of the Fisher and disability, and gastrointestinal malfunction (5, 3 1). One manifes-Stein saccharogenic procedure (10, 12) . In this reaction mixture. tation of the abnormal exocrine gland activity is the high electroa 1:4000 dilution of saliva is usually used. The starch substrate is lyte concentration of C F sweat. The sweat salt concentration is at saturating concentration with respect to the reaction rate. The the prime diagnostic indicator of C F (14) . Pancreatic exocrine resulting increase in reducing sugar concentration is determined function is altered in most but not all C F patients ($31). Salivary using a modification of the Nelson-Somogyi procedure, with 868 glucose as standard (23) . Amylase concentration in starch units per liter is defrned as milligrams of glucose reducing equivalents produced per min per liter of saliva (12) .
a-Amylase p-nitrophenyl a-maltoside (PNPM) activity was determined using a new direct spectrophotometric method (12) . Reaction conditions for this assay were optimized for possible C F factor inhibition of a-amylase. The I-ml reaction mixture contained 0.5 ml whole saliva supernate. The reaction rate is first order with respect to PNPM substrate concentration. a-Amylase activity in PNPM units per liter is defined as micromoles of pnitrophenol produced per min per liter of saliva at a substrate concentration of 1.0 mM (12) .
The protein content of saliva (milligrams of protein per ml saliva) was determined using Miller's (20) modification of the Lowry procedure (16) . Amylase specific activity is defined as starch units per mg protein.
The following materials were purchased from the noted suppliers: PNPM, Regis Chemical Company, Morton Grove, IL; pnitrophenol, Calbiochem, A Grade; starch, Merck soluble starch; gelatin, J. T. Baker, USP grade. All other reagents were of commercially available reagent grade or better. Absorbance was measured with a Gilford 240 recording spectrophotometer, equipped with a thermostatted cell compartment, automatic cell changer, and a digital readout. pH values were measured at ambient room temperature, 22-24". with a Radiometer PHM62 standard pH meter. Distilled deionized water was used to prepare all solutions.
Multiple regression analysis was done using the BMDPIR program (7) at the Health Sciences Computing Facility, UCLA.
RESULTS

INHIBITION OF C F a-AMYLASE
Salivary a-amylase action on starch and PNPM has been compared to determine whether C D F in saliva could be detected by alterations in a-amylase catalytic activity. T o determine whether C D F inhibits a-amylase in saliva, a recently developed assay (12) which should be most sensitive to inhibition was used. For simple enzyme kinetics, one of three types of inhibition patterns are usually observed: noncompetitive, competitive, and uncompetitive (15) . These three modes of inhibition have different sensitivities to the inhibitor at different substrate concentrations. The patterns are summarized for saturating and first order substrate concentrations in Table I .
The starch assay is done under saturating substrate concentration and a 1:4000 dilution of saliva in the reaction mixture. At this dilution the C D F does not affect the amylase starch activity (1 I). Therefore, the starch activity serves as a measure of the total uninhibited salivary amylase activity.
The PNPM activity is determined under first order substrate conditions, with a 1:1 dilution of saliva (12) . These conditions of 
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low substrate and high C D F concentration should be close to the optimum for detection of either noncompetitive or competitive C D F inhibition (Table 1) . Uncompetitive inhibition will not be detected by comparison of the starch and PNPM activities. This mode of inhibition would be detected by comparing the PNPM activities under first order and non-first order substrate conditions.
The effect of Tris on the a-amylase activity as measured by the starch and PNPM assays confirms that amylase does differ in its sensitivity to inhibitors under the two sets of reaction conditions. Tris (90 mM) inhibits starch hydrolysis minimally (I l + 10%).
but markedly inhibits PNPM hydrolysis (64 st I I %). This indicates that Tris is a competitive inhibitor of a-amylase. A Dixon plot (6) at six Tris concentrations from 0-180 mM yields a Ki of 59 st 10 mM for Tris inhibition of amylase PNPM activity.
The ratio of PNPM activity to starch activity for CF. H, and N saliva would indicate whether the C D F in C F and H saliva acts as a competitive or noncompetitive inhibitor of the amylase PNPM activity ( Table 2 ). The C F and N values are not significantly different. Thus there is neither competitive nor nonconipetitive inhibition of PNPM a-amylase activity by CDF. This was examined more vigorously by analysis of variance of the regression coefficients of PNPM units vs. starch units over the three groups. Neither the slopes nor the intercepts differed among the groups ( P = 0.920). We must conclude that even under reaction conditions which should be most sensitive to C D F inhibition of amylase activity, the association of C D F and amylase does n9t have any effect on amylase catalytic activity. This conclusion is confirmed by the observation that 90 mM Tris has the same effect on PNPM activity of CF, H, and N saliva ( Table 2 ). C D F has no detectable effect on either PNPM or Tris binding to a-amylase.
SALIVARY AMYLASE LEVELS
T o further characterize C F saliva samples, the amylase starch activity and protein concentration in CF, H, and N saliva were compared (Table 3) . Although the mean amylase and protein concentrations for C F saliva were found to be higher than the means of the normal saliva ( P < 0.00 1 and P < 0.005, respectively), the specific activities were not significantly different (by Student t-test).
The distribution of values for amylase and protein concentration in CF, H, and N saliva is indicated in Figure 1 . The large range of values is not due to fluctuations in composition of individuals' saliva. Up to eight determinations were made on repeated samples from 17 individuals. Samples were taken during different visits to the clinic or laboratory. Repeated determinations varied by less than I S D of the respective genotype mean.
COMPARISON BY AGE A N D SEX
The amylase specific activity for normal samples appears to peak in preadolescence, and then drops sharply during adolescence (linear regression vs. age, P = 0.032) (Fig. 2A) . The heterozygote samples, from a necessarily older population, are similar to normal adults. C F samples show a drop similar to the normal subjects as age increases from 8-13 years, but have increased activity in the 14-24 year age group. This increase is due entirely to the fact that teenage C F females have elevated amylase specific activity compared to all other groups ( P < 0.005) (see Fig. 3, A 
and D).
Salivary protein concentration appears to be increased for the C F samples in the 14-24 year age group (Fig. 28) . This increase is due to the increased salivary protein concentration of adolescent C F males compared to all other groups ( P < 0.005) (Fig. 3, B and 
E).
Heterozygote mean values fall within the large normal range (Fig. 2B) .
The greatest difference between C F and N samples is in the amylase concentration per ml saliva. Both male and female C F homozygotes have highly elevated salivary amylase concentration in the 14-24 year age group ( P < 0.001) (Fig. 3, C and F) . The normal samples show no significant variation over the age range studied (5-42 years, P = 0.941). The heterozygote sample values appear to increase with age (linear regression for heterozygote females vs. age, P = 0.016) but more H samples as well as N samples in the older age range are needed to determine the significance of the apparent increase.
AMYLASE HYPERSECRETORS
The elevation of mean C F amylase concentration (Table 3) and protein content can be attributed to a group of amylase hypersecretors (Fig. 1) . C F values are distributed in a bimodal fashion, such that the values are either in the normal range or are markedly elevated. Sixteen of 25 C F patients had amylase concentrations within two SDs of the N mean; the remaining 9 values were 3 or more SDs above the N mean (Fig. 1) . Similarly, 19 of 25 C F protein values were in the range of the N mean f 2 SD, whereas the other 7 values were higher than the maximum N values. The protein hypersecretors were also amylase hypersecretors, so that the specific activity of salivary amylase in C F patients was neither bimodal nor different from the N mean.
CF-PARENT CORRELATION
All nine amylase hypersecretors were found in the 14-24 year age group. However, three patients in this age group were not hypersecretors. T o determine whether hypersecretion is related to hereditary factors or to the clinical status of the patient, C F values were correlated to parent values and to Schwachman scores (25) . For 11 patient-parent pairs, patient and parent ages were strongly correlated: P = 0.0017. Amylase concentrations were marginally correlated ( P = 0.075), but protein concentration and amylase specific activity were not correlated for the two groups.
Our patient population included one affected sibling pair. Both the 15-year-old female and her 12-year-old brother had normal amylase concentration (35 and 19 starch units/ml) and protein content (0.440 and 0.438 mg/ml). This along with the weak patient-parent correlation of amylase concentration is consistent with some genetic influence on hypersecretion. However, data on additional affected sibling pairs is needed to define the genetic relationship to hypersecretion.
SHWACHMAN SCORE CORRELATION
The clinical status of the C F patients (assessed by the Shwachman score (25)) correlated marginally ( P = 0.068) with the amylase concentration. The protein and specific activity values did not correlate significantly with the clinical status of the patients.
As expected, the age of the patient and the Shwachman score were correlated ( P = 0.001 1). The regression of Shwachman score vs. age for males had a slope of one half that observed for the females: y = 87 -1 . 2~ vs. y = 89 -2.0~. The regression lines for the two sexes were different (P = 0.029). A sharper decline in female vs. male C F patients with age has been suggested previously (24, 31) .
DISCUSSION
The C D F fraction isolated from C F and H saliva has been found to inhibit mammalian debranching enzyme (1 1). This activ-ity of the C D F has allowed replacement of the unwieldy and erratic oyster gill bioassay for C D F activity (4) with a quantitative enzymatic assay for salivary C D F activity (1 1). Unfortunately, this procedure requires prior separation of the C D F fraction from the salivary amylase, since amylase destroys the debranching enzyme substrate. This separation is cumbersome and the stability of C D F under the conditions of separation is unknown. Therefore, this assay retains major shortcomings.
Ideally, a n enzymatic assay for C D F would use patient materials directly. Since amylase is already present in saliva, and since it is closely associated with the salivary C D F (1, 8,9, 1 I) , the effect of C D F on this enzyme was studied. Unlike its action on the debranching enzyme, C D F was found to have no detectable effect on a-amylase even under reaction conditions designed for maximum competitive and noncompetitive inhibition. Neither the amylase catalytic activity nor its binding to Tris is altered by the presence of CDF.
The 1: 1 dilution used may not be a sufficiently high concentration of C D F to affect a-amylase catalytic activity. The debranching enzyme is about 5 times more sensitive to Tris inhibition than is a-amylase (Ki = 12 mM (13) and Ki = 59 mM, respectively). The concentrated C D F fraction from larger quantities of saliva may yet be found to affect a-amylase activity. However, for direct measurements on C F body fluids, a more sensitive assay must be developed. Although the C D F and a-amylase are closely associated in C F saliva, their mode of interaction remains to be defined.
T o provide information on the basis for elevated a-amylase levels in CF, the amylase activity and protein concentration of CF, H, and N saliva samples were compared as a function of age and sex. Our results (Table I) A: amylase specific activity; B: protein concentration; C: amylase wncentration in starch units per ml. age dependent (Fig. 2 ). This variation with age explains previously described differences between C F and N saliva (2. 3. 17). For example, Blomfield's group reported that amylase concentration was elevated in the parotid saliva of a group of 3-to 17-year-old C F patients (2) . Some of Blomfield's patients were hypersecretors. The same group subsequently reported that amylase levels in 9-to 13-year-old C F patients were not significantly different from the N mean (3). We .lave found a sharp increase in C F whole saliva amylase concentration in patients between 14 and 24 years of age ( P < 0.005). The cause for this difference between C F children, adolescents, and young adults remains to be determined. Normal saliva shows no significant change in amylase concentration from 5-42 years of age. In contrast to the constant amylase concentration of normal saliva, the mean specific activity of normal saliva decreases dramatically with increasing age ( P = 0.032) (Fig. 2) . C F males show a similar decrease (Fig. 3) but C F females demonstrate an increase in specific activity which peaks at 17 years. This change with age may represent the functional development of the various salivary glands (26) and possible hormonal influences (cf: Ref. 26) which depend upon both age and sex. In any event, these data emphasize the need for age-and sex-matched controls in all studies of salivarv com~osition.
The existence of a subgroup of amylase hypersecretors in the C F patient population is another example of the heterogeneity of this disease. The basis for hypersecretion of amylase in C F remains to be elucidated. Both hereditary and clinical factors are rnarginally correlated to the elevated amylase concentrations. The high amylase values suggest that the parotid gland may be secreting a higher proportion of the whole saliva than normal. One might invoke three hypotheses to account for this. First, the parotid gland may be contributing a greater portion of the whole saliva because of plugging of the mucus-secreting glands. This type of plugging in the pancreas accounts for progressive loss of pancreatic exocrine function in C F (5, 31) . Second, the parotid gland may hypersecrete in order to maintain the serum amylase levels. Serum pancreatic amylase is decreased in C F patients with pancreatic insufficiency yet the total serum amylase is maintained in the normal range by salivary isozymes (26, 29, 30 ). If this is the case, hypersecretion of amylase in C F saliva may prove to be a sensitive, indirect measure of deteriorating pancreatic exocrine function. Third, amylase hypersecretion may be more directly related to a primary defect in the secretory mechanism in CF. Amylase release is mediated by intra-and extracellular Na+ and Ca"' (22). Alterations in electrolyte transport or permeability could affect secretory function. Amylase secretion is altered in cystic fibrosis. Its role in the pathophysiology of the disease remains to be determined.
